Skip to main content
Diagnostics

Brain PET Scan: Seeing What Your Brain Is Actually Doing

An MRI shows what your brain looks like. A PET scan shows what it’s doing. FDG-PET maps glucose metabolism across every region of the brain, revealing functional deficits that structural imaging cannot detect—often years before symptoms become obvious.

Schedule a ConsultationCall (912) 268-3097

The Scan That Shows Function, Not Just Structure

Positron emission tomography works on a straightforward principle. Neurons consume glucose. Active, healthy neurons consume more of it. Damaged, degenerating, or dysfunctional neurons consume less. By injecting a radiolabeled glucose analog—fluorodeoxyglucose, or FDG—and imaging where it accumulates, we produce a metabolic map of the entire brain.

The clinical value of this is difficult to overstate. Structural MRI can show atrophy, lesions, and white matter disease, but it cannot tell you whether a brain region that looks anatomically intact is actually functioning. FDG-PET can. Minoshima and colleagues (1997, Annals of Neurology) demonstrated that temporoparietal hypometabolism on FDG-PET distinguishes Alzheimer’s disease from other dementias with sensitivity exceeding 90 percent—often before volumetric MRI shows significant atrophy.

This is why a patient can have a “normal MRI” and still have a significant functional deficit. The structure is still there. The metabolic machinery driving it is not. PET catches this gap. Foster et al. (2007, Brain) showed that distinct metabolic signatures on FDG-PET reliably differentiate Alzheimer’s disease from frontotemporal dementia—a distinction that changes treatment, prognosis, and family planning entirely. Getting the diagnosis wrong has consequences that compound over years.

At The Neurogenesis Project, Dr. Orr does not read PET scans in isolation. Every scan is interpreted alongside the neurological examination, cognitive testing, laboratory findings, and structural imaging—because a metabolic pattern means different things in different clinical contexts. The scan is a tool. The interpretation is what changes the patient’s trajectory.

When Brain PET Changes the Diagnosis

PET imaging is not a screening test. It is a clinical tool ordered when the diagnostic question requires functional information that structural imaging and laboratory evaluation cannot provide. There are several well-established indications where FDG-PET directly changes management.

In suspected Alzheimer’s disease, the pattern is characteristic: bilateral temporoparietal hypometabolism with relative preservation of primary sensorimotor and visual cortices, as described by Herholz et al. (2002, NeuroImage). This metabolic pattern can be present while the MRI still appears unremarkable, making PET the more sensitive early marker. Patients who are told they have “age-related memory changes” on the basis of a normal MRI may already have a metabolic signature consistent with early neurodegeneration.

Frontotemporal dementia presents with a different metabolic pattern entirely—frontal and anterior temporal hypometabolism. Distinguishing this from Alzheimer’s is not academic. The medications used for Alzheimer’s are ineffective and potentially harmful in frontotemporal dementia. The behavioral trajectory, caregiver needs, and genetic counseling implications are different. Rabinovici et al. (2011, Neurology) showed that FDG-PET improved diagnostic accuracy for dementia subtype classification by approximately 15 percent over clinical evaluation alone.

In epilepsy, interictal FDG-PET identifies the seizure focus as a region of hypometabolism when the patient is not actively seizing. This is critical for surgical planning when scalp EEG and MRI have not localized the focus. In neuro-oncology, PET distinguishes high-grade from low-grade tumors based on metabolic activity and differentiates tumor recurrence from treatment-related changes on follow-up imaging.

Clinical Applications

FDG-PET provides actionable diagnostic information across multiple neurological conditions. Dr. Orr determines whether PET is indicated based on your clinical presentation and existing workup.

Alzheimer’s Evaluation

Bilateral temporoparietal hypometabolism is the hallmark FDG-PET pattern in Alzheimer’s disease. Detectable before significant structural atrophy appears on MRI, enabling earlier intervention and metabolic optimization strategies.

Dementia Differentiation

Frontotemporal dementia, Lewy body dementia, and Alzheimer’s each produce distinct metabolic signatures on PET. Accurate subtype diagnosis changes medication selection, prognosis, and family genetic counseling.

Seizure Localization

Interictal FDG-PET identifies the epileptogenic zone as a region of focal hypometabolism. Critical for surgical planning when EEG and MRI have not localized the seizure focus adequately.

Tumor Grading

High-grade brain tumors are hypermetabolic. Low-grade tumors are hypometabolic. FDG-PET differentiates between them and distinguishes tumor recurrence from radiation necrosis on follow-up imaging.

Traumatic Brain Injury

Regional hypometabolism on PET reveals functional deficits from TBI that conventional MRI and CT miss entirely. Particularly valuable in concussion patients with persistent symptoms and normal structural imaging.

Baseline Brain Health

For patients pursuing proactive brain health optimization, a baseline FDG-PET provides a functional reference point against which future scans can be compared to detect change before symptoms emerge.

What to Expect and What It Costs

Brain PET imaging at The Neurogenesis Project costs $1,750. This includes the FDG radiotracer, the scan acquisition, and Dr. Orr’s comprehensive clinical interpretation correlated with your full neurological workup.

You will fast for four to six hours before the scan. On arrival, we check your blood glucose to ensure optimal tracer uptake. After the FDG injection, you rest quietly in a dimly lit room for 30 to 45 minutes while the tracer distributes throughout the brain. Active neurons absorb more tracer than inactive ones. The scan itself takes approximately 20 to 30 minutes. Most patients are in and out within 90 minutes.

Dr. Orr reviews every PET scan personally. He does not delegate interpretation to a general radiologist reading the scan without clinical context. The metabolic patterns on FDG-PET are meaningful only when interpreted alongside the patient’s neurological examination, cognitive testing results, laboratory findings, and structural imaging. A region of hypometabolism in the temporal lobe means something different in a patient with progressive memory loss than in a patient with medically refractory epilepsy. The scan provides data. The neurologist provides interpretation.

We provide detailed superbills and medical documentation for patients who wish to submit to their insurance for potential out-of-network reimbursement.

Related Diagnostics & Treatments

Brain MRI & Advanced Neuroimaging

Structural imaging that complements PET. Our NeuroCognitive MRI protocol reveals anatomy, connectivity, and white matter integrity that standard outpatient imaging overlooks. Most comprehensive when paired with PET.

Brain Health Lab Panels

Metabolic, inflammatory, and genomic blood work that identifies the biochemical drivers behind the functional deficits PET reveals. Imaging shows where the problem is; labs help explain why.

Alzheimer’s Prevention

PET is the most sensitive tool for detecting early Alzheimer’s pathology. Our prevention program uses PET findings alongside APOE genotyping and metabolic optimization to intervene before irreversible damage occurs.

Frequently Asked Questions

What does a brain PET scan actually show?+
A brain PET scan measures glucose metabolism — the rate at which different brain regions consume energy. Neurons that are functioning normally take up glucose at predictable rates. Regions that are damaged, degenerating, or functionally impaired show reduced uptake, appearing as areas of hypometabolism on the scan. This provides a functional map of your brain that structural imaging like MRI cannot replicate. An MRI shows anatomy; a PET scan shows activity.
How is a brain PET scan different from a brain MRI?+
MRI produces detailed images of brain structure — gray matter volume, white matter integrity, the presence of lesions or tumors. PET produces images of brain function — which regions are metabolically active and which are not. A brain region can appear structurally normal on MRI while being functionally impaired on PET. This is particularly common in early neurodegenerative disease, where metabolic decline precedes visible structural atrophy by years. Both modalities provide different and complementary information, which is why Dr. Orr frequently orders them together.
How much does a brain PET scan cost?+
Brain PET imaging at The Neurogenesis Project is $1,750. This includes the FDG radiotracer, the scan itself, and Dr. Orr's clinical interpretation with a detailed written report correlating PET findings with your neurological examination, lab work, and any structural imaging. We provide superbills for patients who wish to submit to their insurance carrier for potential out-of-network reimbursement.
Is the PET scan safe? What about radiation exposure?+
FDG-PET uses a small amount of a radioactive glucose tracer that is injected intravenously before the scan. The radiation dose from a single brain PET scan is approximately 5-7 millisieverts, comparable to one to two years of natural background radiation exposure. The tracer has a short half-life of approximately 110 minutes and is eliminated from the body within hours. For the clinical questions a brain PET answers — particularly in suspected neurodegenerative disease or seizure localization — the diagnostic value substantially outweighs the minimal radiation exposure.
What should I expect during the scan?+
You will receive an intravenous injection of FDG, a radioactive glucose analog. After injection, you rest quietly in a dimly lit room for approximately 30 to 45 minutes while the tracer distributes throughout your brain — neurons that are more metabolically active absorb more tracer. You then lie still in the PET/CT scanner for approximately 20 to 30 minutes while images are acquired. The entire visit takes about 90 minutes. There is no pain beyond the IV placement, and no sedation is required.
Who should consider getting a brain PET scan?+
Brain PET imaging is clinically indicated for several specific scenarios: patients with cognitive decline where the pattern of degeneration needs to be identified (Alzheimer's versus frontotemporal dementia versus Lewy body disease), patients with seizures that have not been localized by EEG and MRI alone, patients with brain lesions that need metabolic characterization to guide treatment planning, and patients who want a baseline functional assessment of brain health. Dr. Orr determines whether PET is appropriate based on your clinical presentation, examination findings, and existing imaging.

See What Your Brain Is Actually Doing

A normal MRI does not mean a normal brain. FDG-PET reveals functional deficits that structural imaging misses—and that information changes what we can do for you. Dr. Orr is accepting new patients at The Neurogenesis Project in St. Marys, Georgia.

Schedule Your Evaluation(912) 268-3097